Diphenylacetic Acid

Diphenylacetic Acid

SCHEMBL3885595

O=C(O)C(c1ccccc1)c1ccccc1.O=C(O)c1ccccc1-c1ccc(-c2ccccc2)cc1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HNF4A P41235 3/20 0.50
BCAT2 O15382 1/20 0.49
FABP3 P05413 1/20 0.46
FABP4 P15090 1/20 0.46
FABP5 Q01469 1/20 0.46
CDC25B P30305 1/20 0.46
ATM Q13315 1/20 0.46
BRS3 P32247 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
FNTA P49354 1/20 0.45
FNTB P49356 1/20 0.45
LTB4R2 Q9NPC1 4/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
PTPN1 P18031 1/20 0.44
CHRNB2 P17787 1/20 0.44
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL505412 0.86 HNF4A (0.64) HNF4ABCAT2FABP3FABP4FABP5
SCHEMBL32677772 0.86 HNF4A (0.64) HNF4ABCAT2FABP3FABP4FABP5
SCHEMBL32677769 0.86 HNF4A (0.64) HNF4ABCAT2FABP3FABP4FABP5
Biphenyl SCHEMBL9292498 0.84 HNF4A (0.67) HNF4ABCAT2FABP3FABP4FABP5
SCHEMBL11554621 0.84 HNF4A (0.61) HNF4ABCAT2FABP3FABP4FABP5
SCHEMBL4538108 0.82 PTGS2 (0.61) CHRNB2CHRNA4PTGS2SRC
SCHEMBL133057 0.82 HNF4A (0.69) HNF4ABCAT2FABP3FABP4FABP5
SCHEMBL18759613 0.82 HNF4A (0.63) HNF4ABCAT2FABP3FABP4FABP5
SCHEMBL30292805 0.82 HNF4A (0.63) HNF4ABCAT2FABP3FABP4FABP5
Benzene SCHEMBL1403559 0.82 HNF4A (0.69) HNF4ABCAT2FABP3FABP4FABP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013210-A1 PURINE DERIVATIVES WITH ACTIVITY TO THE ADENOSINE A2A RECEPTOR Novartis Ag (CH) 2009-01-14 EP disclosed
WO-2007121919-A1 PURINE DERIVATIVES WITH ACTIVITY TO THE ADENOSINE A2A RECEPTOR NOVARTIS AG (CH) 2007-11-01 WO disclosed